By successfully encapsulating a vaccine into a spider silk microparticle, Swiss and German researchers have discovered a novel technique that will help fight cancer and certain infectious diseases.
To fight cancer, researchers increasingly use vaccines that stimulate the immune system to identify and destroy tumour cells. However, the desired immune response is is not always guaranteed. In order to strengthen the efficacy of vaccines on the immune system – and in particular on T lymphocytes, specialized in the detection of cancer cells – researchers from the universities of Geneva (UNIGE), Freiburg (UNIFR), Munich, and Bayreuth, in collaboration with the German company AMSilk, have developed spider silk microcapsules capable of delivering the vaccine directly to the heart of immune cells. This process, published in the journal Biomaterials, could also be applied to preventive vaccines to protect against infectious diseases, and constitutes an important step towards vaccines that are stable, easy to use, and resistant to the most extreme storage conditions.
Our immune system is largely based on two types of cells: B lymphocytes, which produce the antibodies needed to defend against various infections, and T lymphocytes. In the case of cancer and certain infectious diseases such as tuberculosis, T lymphocytes need to be stimulated. However, their activation mechanism is more complex than that of B lymphocytes: to trigger a response, it is necessary to use a peptide, a small piece of protein which, if injected alone, is rapidly degraded by the body even before reaching its target.
“To develop immunotherapeutic drugs effective against cancer, it is essential to generate a significant response of T lymphocytes,» says Professor Carole Bourquin, a specialist in antitumor immunotherapies at the faculties of medicine and science of the UNIGE, who directed this work. “As the current vaccines have only limited action on T-cells, it is crucial to develop other vaccination procedures to overcome this issue.”
A virtually indestructible capsule
Scientists used synthetic spider silk biopolymers—a lightweight, biocompatible, non-toxic material that is highly resistant to degradation from light and heat. “We recreated this special silk in the lab to insert a peptide with vaccine properties,» explains Thomas Scheibel, a world specialist of spider silk from the University of Bayreuth who participated in the study. “The resulting protein chains are then salted out to form injectable microparticles.”
Silk microparticles form a transport capsule that protects the vaccine peptide from rapid degradation in the body, and delivers the peptide to the center of the lymph node cells, thereby considerably increasing T lymphocyte immune responses. “Our study has proved the validity of our technique”, reveals Carole Bourquin. “We have demonstrated the effectiveness of a new vaccination strategy that is extremely stable, easy to manufacture and easily customizable.”
Towards a new vaccine model
The synthetic silk biopolymer particles demonstrate a high resistance to heat, withstanding over 100°C for several hours without damage. In theory, this process would make it possible to develop vaccines that do not require adjuvants and cold chains. An undeniable advantage, especially in developing countries where one of the great difficulties is the preservation of vaccines. One of the limitations of this process, however, is the size of the microparticles: while the concept is in principle applicable to any peptide, which are all small enough to be incorporated into silk proteins, further research is needed to see if it is also possible to incorporate the larger antigens used in standard vaccines, especially against viral diseases.
When science imitates nature
“More and more, scientists are trying to imitate nature in what it does best”, adds Scheibel. “This approach even has a name: bioinspiration, which is exactly what we have done here.” The properties of spider silk make it a particularly interesting product: biocompatible, solid, thin, biodegradable, resistant to extreme conditions and even antibacterial, one can imagine multiple applications, including wound dressings or sutures.
Learn more: A new kind of vaccine based on spider silk
Receive an email update when we add a new VACCINES article.
The Latest on: Vaccine delivery
via Google News
The Latest on: Vaccine delivery
- Guide to inactive vaccine administration for pullet rearers on February 18, 2019 at 7:29 am
Vaccine will normally be ordered by the farm vet on behalf of the producer and delivered directly to the unit. Merial Animal Health’s Gavin Kelly offers some tips On delivery, inactivated vaccines sho... […]
- mRNA Vaccines & Therapeutics market detailed in new research report on February 18, 2019 at 2:02 am
Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies. mRNA Vaccines & Therapeutics ... […]
- Vaccine Adjuvants Market Consumption Volume, Competitive Dynamics And Worldwide Overview 2028 on February 17, 2019 at 9:22 pm
Adjuvant vaccines improve the efficacy of vaccines in infants, the elderly population, as the antigen delivery systems for the uptake of antigens is by the mucosa. Increasing prevalence of infectious ... […]
- Tiny, Motorized Pill Delivers Vaccine to Mouse Intestine on February 15, 2019 at 1:46 pm
Wei et al., “Biomimetic micromotor enables active delivery of antigens for oral vaccination,” Nano Letters, doi:10.1021/acs.nanolett.8b05051, 2019. copyright 2019 american chemical society A new type ... […]
- Oral Vaccine Market Will Surge at 7.1% CAGR to Reach 3480 Million US$ by the End of 2025: QY Research, Inc. on February 15, 2019 at 3:31 am
Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral deliv... […]
- Taking Vaccines the Last Mile on February 15, 2019 at 2:55 am
No single preventive health intervention is more cost-effective than immunization. And yet, despite significant progress on expanding global immunization, coverage has stalled at about 85% in recent y... […]
- MSD Animal Health announces vaccine verification tool collaboration at IPPE 2019 on February 13, 2019 at 1:56 am
In ovo vaccination technology that offers earlier immunity, uniform vaccine delivery and reduced stress on the birds, as well as lower labour costs Constant pressure spray technology that optimises ac... […]
- Dendritic cell targeted Ccl3- and Xcl1-fusion DNA vaccines differ in induced immune responses and optimal delivery site on February 12, 2019 at 2:35 am
DNA vaccination represents a highly attractive immunization strategy due to the speed and cost effectiveness at which novel subunit vaccines can be generated. Unfortunately, the issue of low immunogen... […]
- Self-Propelling Micromotors Deliver Oral Vaccines on February 11, 2019 at 1:44 am
“Our work provides a proof-of-concept highlighting the benefits of active oral delivery for vaccine development, opening the door for a new set of applications, in which biomimetic motor technology ca... […]
via Bing News